Lobbying client
TETRAPHASE PHARMACEUTICALS
Pharmaceutical Development
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Filings
11
Filed by
2
Reported in-house
—
Reported by firms
$150,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2009 to 2015
Filings
2 filings for 2012, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination Amendment 2nd Quarter 2012
|
FABIANI & COMPANY | — reported |
|
2nd Quarter - Reportreplaced 2nd Quarter 2012
|
FABIANI & COMPANY | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| FABIANI & COMPANY | 5 | $120,000 |
| THE MCMANUS GROUP | 3 | $30,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 9 |
| Defense | DEF | 5 |
| Veterans | VET | 5 |
Bills named in its filings
Bill numbers found in the filers' descriptions, most often named first.
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.